Company / Book Value per Share
Myriad Genetics, Inc. Book Value per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Book Value per Share
$4.532
FY2025
5-year range
$4.532 / $13.708
FY2021-FY2025
Trend
-48.3%
vs FY2024
Sector context
#110 of 209
Health Care
What the data says
At $4.532, Myriad Genetics, Inc.'s book value per share ranks #110 of 209 in the Health Care sector. Book Value per Share has declined for 4 consecutive years, from $13.708 in FY2021 to $4.532 in FY2025.
Based on SEC 10-K filings.
$4.532 in FY2025 with a 5-year CAGR of -18.9%.
Declined from $10.387 to $4.532 over the past 2 years.
Health Care sector context is included.
Book Value per Share over time
Growth rates
- 3-Year CAGR
- -27.8%
- 5-Year CAGR
- -18.9%
- 10-Year CAGR
- -
Sector benchmark
#110 of 209 in Health CareTop 53% of 209This company $4.532 Sector average $215.686
▼
-97.9% below sector average
Key checks
Key Insights
- Myriad Genetics, Inc.'s book value per share has declined for 4 consecutive years.
- 5-year CAGR of -18.9%, indicating a declining trend.
- In FY2025, book value per share decreased 48.3% year-over-year.
- Ranks #110 out of 209 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score -1.23 (distress zone, below 1.8 threshold)
- Negative profit margin: -15.2%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $4.532 | -48.3% |
| FY2024 | $8.764 | -15.6% |
| FY2023 | $10.387 | -13.8% |
| FY2022 | $12.052 | -12.1% |
| FY2021 | $13.708 | +6.4% |
| FY2020 | $12.88 | -18.3% |
| FY2019 | $15.758 | +12.4% |
| FY2018 | $14.022 | +34.1% |
| FY2017 | $10.454 | +13.9% |
| FY2016 | $9.176 | +14.5% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026